BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mani S, Toapanta FR, McArthur MA, Qadri F, Svennerholm AM, Devriendt B, Phalipon A, Cohen D, Sztein MB. Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development. Vaccine 2019;37:4787-93. [PMID: 31230883 DOI: 10.1016/j.vaccine.2019.03.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cox E, Aloulou M, Fleckenstein JM, Schäffer C, Sjöling Å, Schüller S, Hanevik K, Devriendt B, Zhang W, Svennerholm AM, Dudley EG. The Intriguing Interaction of Escherichia coli with the Host Environment and Innovative Strategies To Interfere with Colonization: a Summary of the 2019 E. coli and the Mucosal Immune System Meeting. Appl Environ Microbiol 2020;86:e02085-20. [PMID: 33008822 DOI: 10.1128/AEM.02085-20] [Reference Citation Analysis]
2 Berzosa M, Nemeskalova A, Zúñiga-ripa A, Salvador-bescós M, Larrañeta E, Donnelly RF, Gamazo C, Irache JM. Immune Response after Skin Delivery of a Recombinant Heat-Labile Enterotoxin B Subunit of Enterotoxigenic Escherichia coli in Mice. Pharmaceutics 2022;14:239. [DOI: 10.3390/pharmaceutics14020239] [Reference Citation Analysis]
3 Qi L, Mao H, Lu X, Shi T, Wang J. Cinnamaldehyde Promotes the Intestinal Barrier Functions and Reshapes Gut Microbiome in Early Weaned Rats. Front Nutr 2021;8:748503. [PMID: 34712688 DOI: 10.3389/fnut.2021.748503] [Reference Citation Analysis]
4 Venkatesan MM, Ballou C, Barnoy S, McNeal M, El-Khorazaty J, Frenck R, Baqar S. Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding. PLoS One 2021;16:e0259361. [PMID: 34793505 DOI: 10.1371/journal.pone.0259361] [Reference Citation Analysis]
5 Fleckenstein JM. Confronting Challenges to Enterotoxigenic Escherichia coli Vaccine Development. Front Trop Dis 2021;2:709907. [DOI: 10.3389/fitd.2021.709907] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Adeleke VT, Adeniyi AA, Adeleke MA, Okpeku M, Lokhat D. The design of multiepitope vaccines from plasmids of diarrheagenic Escherichia coli against diarrhoea infection: Immunoinformatics approach. Infect Genet Evol 2021;91:104803. [PMID: 33684568 DOI: 10.1016/j.meegid.2021.104803] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kuhlmann FM, Laine RO, Afrin S, Nakajima R, Akhtar M, Vickers T, Parker K, Nizam NN, Grigura V, Goss CW, Felgner PL, Rasko DA, Qadri F, Fleckenstein JM. Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infection with Enterotoxigenic E. coli. Infect Immun 2021;89:e00041-21. [PMID: 33558320 DOI: 10.1128/IAI.00041-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]